vs

Side-by-side financial comparison of Genpact LTD (G) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Genpact LTD). Genpact LTD runs the higher net margin — 10.8% vs -58.9%, a 69.7% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 5.6%). Invesco produced more free cash flow last quarter ($432.2M vs $269.0M). Over the past eight quarters, Genpact LTD's revenue compounded faster (8.0% CAGR vs 7.1%).

Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, Genpact employs more than 125,000 people and provides services to clients in over 30 countries worldwide. Genpact is listed on the NYSE and generated revenues of US$4.48 billion in 2023.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

G vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.3× larger
IVZ
$1.7B
$1.3B
G
Growing faster (revenue YoY)
IVZ
IVZ
+0.6% gap
IVZ
6.2%
5.6%
G
Higher net margin
G
G
69.7% more per $
G
10.8%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$163.2M more FCF
IVZ
$432.2M
$269.0M
G
Faster 2-yr revenue CAGR
G
G
Annualised
G
8.0%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
G
G
IVZ
IVZ
Revenue
$1.3B
$1.7B
Net Profit
$143.1M
$-995.9M
Gross Margin
36.6%
Operating Margin
14.8%
-86.2%
Net Margin
10.8%
-58.9%
Revenue YoY
5.6%
6.2%
Net Profit YoY
0.8%
-575.8%
EPS (diluted)
$0.82
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
G
G
IVZ
IVZ
Q4 25
$1.3B
$1.7B
Q3 25
$1.3B
$1.6B
Q2 25
$1.3B
$1.5B
Q1 25
$1.2B
$1.5B
Q4 24
$1.2B
$1.6B
Q3 24
$1.2B
$1.5B
Q2 24
$1.2B
$1.5B
Q1 24
$1.1B
$1.5B
Net Profit
G
G
IVZ
IVZ
Q4 25
$143.1M
$-995.9M
Q3 25
$145.8M
$356.4M
Q2 25
$132.7M
$197.4M
Q1 25
$130.9M
$171.1M
Q4 24
$141.9M
$209.3M
Q3 24
$132.8M
$55.0M
Q2 24
$122.0M
$132.2M
Q1 24
$116.9M
$141.5M
Gross Margin
G
G
IVZ
IVZ
Q4 25
36.6%
Q3 25
36.4%
Q2 25
35.9%
Q1 25
35.3%
Q4 24
35.7%
Q3 24
35.6%
Q2 24
35.4%
Q1 24
35.0%
Operating Margin
G
G
IVZ
IVZ
Q4 25
14.8%
-86.2%
Q3 25
14.8%
16.5%
Q2 25
14.3%
14.1%
Q1 25
15.1%
18.1%
Q4 24
15.2%
19.6%
Q3 24
15.0%
6.6%
Q2 24
14.5%
13.9%
Q1 24
14.1%
14.4%
Net Margin
G
G
IVZ
IVZ
Q4 25
10.8%
-58.9%
Q3 25
11.3%
21.7%
Q2 25
10.6%
13.0%
Q1 25
10.8%
11.2%
Q4 24
11.4%
13.1%
Q3 24
11.0%
3.6%
Q2 24
10.4%
8.9%
Q1 24
10.3%
9.6%
EPS (diluted)
G
G
IVZ
IVZ
Q4 25
$0.82
$-2.61
Q3 25
$0.83
$0.66
Q2 25
$0.75
$-0.03
Q1 25
$0.73
$0.38
Q4 24
$0.80
$0.46
Q3 24
$0.74
$0.12
Q2 24
$0.67
$0.29
Q1 24
$0.64
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
G
G
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$1.2B
$1.0B
Total DebtLower is stronger
$1.5B
$1.8B
Stockholders' EquityBook value
$2.5B
$12.2B
Total Assets
$5.8B
$27.1B
Debt / EquityLower = less leverage
0.60×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
G
G
IVZ
IVZ
Q4 25
$1.2B
$1.0B
Q3 25
$740.8M
$973.1M
Q2 25
$663.3M
$922.7M
Q1 25
$561.6M
$821.7M
Q4 24
$671.6M
$986.5M
Q3 24
$1.0B
$1.0B
Q2 24
$914.2M
$878.5M
Q1 24
$478.4M
$895.7M
Total Debt
G
G
IVZ
IVZ
Q4 25
$1.5B
$1.8B
Q3 25
$1.2B
$1.6B
Q2 25
$1.2B
$1.9B
Q1 25
$1.2B
$964.8M
Q4 24
$1.2B
$890.6M
Q3 24
$1.6B
$890.3M
Q2 24
$1.6B
$890.1M
Q1 24
$1.2B
$1.3B
Stockholders' Equity
G
G
IVZ
IVZ
Q4 25
$2.5B
$12.2B
Q3 25
$2.5B
$14.0B
Q2 25
$2.6B
$13.9B
Q1 25
$2.5B
$14.7B
Q4 24
$2.4B
$14.6B
Q3 24
$2.4B
$14.8B
Q2 24
$2.3B
$14.6B
Q1 24
$2.3B
$14.6B
Total Assets
G
G
IVZ
IVZ
Q4 25
$5.8B
$27.1B
Q3 25
$5.4B
$28.4B
Q2 25
$5.3B
$28.5B
Q1 25
$4.9B
$28.1B
Q4 24
$5.0B
$27.0B
Q3 24
$5.3B
$27.5B
Q2 24
$5.2B
$27.2B
Q1 24
$4.7B
$28.1B
Debt / Equity
G
G
IVZ
IVZ
Q4 25
0.60×
0.15×
Q3 25
0.47×
0.12×
Q2 25
0.47×
0.14×
Q1 25
0.50×
0.07×
Q4 24
0.51×
0.06×
Q3 24
0.68×
0.06×
Q2 24
0.70×
0.06×
Q1 24
0.54×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
G
G
IVZ
IVZ
Operating Cash FlowLast quarter
$286.7M
$455.8M
Free Cash FlowOCF − Capex
$269.0M
$432.2M
FCF MarginFCF / Revenue
20.4%
25.5%
Capex IntensityCapex / Revenue
1.3%
1.4%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$734.7M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
G
G
IVZ
IVZ
Q4 25
$286.7M
$455.8M
Q3 25
$308.4M
$606.2M
Q2 25
$177.4M
$547.9M
Q1 25
$40.4M
$-84.6M
Q4 24
$203.2M
$316.9M
Q3 24
$228.5M
$438.4M
Q2 24
$209.3M
$489.1M
Q1 24
$-25.6M
$-54.4M
Free Cash Flow
G
G
IVZ
IVZ
Q4 25
$269.0M
$432.2M
Q3 25
$292.0M
$586.4M
Q2 25
$155.1M
$530.4M
Q1 25
$18.5M
$-108.0M
Q4 24
$183.5M
$309.9M
Q3 24
$208.7M
$410.0M
Q2 24
$190.0M
$462.4M
Q1 24
$-49.6M
$-75.4M
FCF Margin
G
G
IVZ
IVZ
Q4 25
20.4%
25.5%
Q3 25
22.6%
35.7%
Q2 25
12.4%
35.0%
Q1 25
1.5%
-7.1%
Q4 24
14.7%
19.5%
Q3 24
17.2%
27.1%
Q2 24
16.2%
31.2%
Q1 24
-4.4%
-5.1%
Capex Intensity
G
G
IVZ
IVZ
Q4 25
1.3%
1.4%
Q3 25
1.3%
1.2%
Q2 25
1.8%
1.2%
Q1 25
1.8%
1.5%
Q4 24
1.6%
0.4%
Q3 24
1.6%
1.9%
Q2 24
1.6%
1.8%
Q1 24
2.1%
1.4%
Cash Conversion
G
G
IVZ
IVZ
Q4 25
2.00×
Q3 25
2.11×
1.70×
Q2 25
1.34×
2.78×
Q1 25
0.31×
-0.49×
Q4 24
1.43×
1.51×
Q3 24
1.72×
7.97×
Q2 24
1.72×
3.70×
Q1 24
-0.22×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

G
G

High Tech And Manufacturing$525.3M40%
Consumer And Healthcare$445.8M34%
Financial Services$348.2M26%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons